Coral Laboratories Limited

BSE: 524506
Coral Laboratories Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24231MH1997PLC422233 Incorporated 06 February 1997 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - BSE: 524506 Public Limited Company pharma
Data last updated
Revenue · FY 2026
₹85.9 Cr
▼ 25.31% YoY
EBITDA · FY 2026
₹25.11 Cr
▼ 28.96% YoY
Net profit · FY 2026
₹16.38 Cr
▼ 32.18% YoY
Authorised capital
₹10 Cr
Registered with MCA
Paid-up capital
₹3.57 Cr
Issued & subscribed
Open charges
₹31.05 Cr
Satisfied ₹1.97 Cr
Company age
29 yrs
Est. 1997
Employees · EPFO
103
Latest available

About Coral Laboratories Limited

Data last updated: 23 December 2025

Coral Laboratories Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 06 February 1997, the company has been in operation for over 29 years.

Registered with ROC Mumbai under CIN L24231MH1997PLC422233. Listed on BSE: 524506.

Capital: an authorised share capital of ₹10 Cr and a paid-up capital of ₹3.57 Cr. Formerly known as Coral Laboratories Private Limited. It is led by directors including Sushma Shashi Kadkade and Malay Sureshkumar Doshi.

Last AGM: 26 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2024, the company reported a revenue of ₹90.29 Cr, a growth of 6% compared to the previous year.

The company has a workforce of approximately 103 employees as per the latest available data.

The company is associated with 1 brand - Coral Laboratories. As per MCA filings, the company has open charges of ₹31.05 Cr and satisfied charges of ₹1.97 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website corallab.com.

Company Details of Coral Laboratories Limited
CIN L24231MH1997PLC422233
Registration Number 422233
Incorporation Date 06 February 1997
ROC Mumbai
Listing Status Listed (BSE: 524506)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Key People
Girish Madanlal Dhameja Whole-Time Director Sushma Shashi Kadkade Nodal Officer Malay Sureshkumar Doshi Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    corallab.com
  • Social Media
    **************
  • Registered Address
    Shed No. 3B Patanwala Compound, Opp Shreyas Lbs Marg Ghatkopar (West), Mumbai, Maharashtra, India – 400086
  • Industry
    Pharma, Drug Formulation & Development
Company report
Coral Laboratories Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Coral Laboratories Limited report

Financials, compliance, directors, charges, ownership and filings for Coral Laboratories Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Coral Laboratories Limited

Coral Laboratories Limited has one previous CIN (Corporate Identification Number): L24231GJ1997PLC031669. The current CIN is L24231MH1997PLC422233, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L24231MH1997PLC422233 Current
L24231GJ1997PLC031669 Previous

Associated Brands with Coral Laboratories Limited

Coral Laboratories Limited operates one associated brand: Coral Laboratories. These brands represent Coral Laboratories Limited's diversified market presence and brand portfolio.

Brand Description Website
Coral Laboratories
Manufacturer of generic drugs corallab.com

Auditor Details of Coral Laboratories Limited

Coral Laboratories Limited is audited by S C Mehra & Associates LLP (ICAI peer reviewed, certificate valid till 2027-03-31) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.

Name Financial year Audit opinion
S C Mehra & Associates LLP (ICAI peer reviewed, certificate valid till 2027-03-31) FY 2026 Declaration of unmodified opinion

Board of Directors of Coral Laboratories Limited

Coral Laboratories Limited is currently managed by 7 directors, with 20 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Sushma Shashi Kadkade Nodal Officer 08 Jan 2024 2 Years 6 Months Current
Malay Sureshkumar Doshi Director 27 May 2021 5 Years 1 Months Current
Saurabh Kamlesh Shah Director 28 May 2019 7 Years 1 Months Current
Rajendrasinh Ajitsinh Rana Director 03 Sep 2021 4 Years 10 Months Current
Girish Madanlal Dhameja Whole-Time Director 26 May 2017 9 Years 1 Months Current
Pooja Sanjiv Hindia Director 09 Aug 2024 1 Years 11 Months Current
Showing 6 of 7 current directors. View all directors

Financials of Coral Laboratories Limited FY 2026 filings available

Coral Laboratories Limited reported revenue of ₹85.9 Cr (down 25.31% YoY) for FY 2026. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2026
₹85.9 Cr ▼ 25.31%
Profit · FY 2026
₹16.38 Cr ▼ 32.18%
EBITDA · FY 2026
₹25.11 Cr ▼ 28.96%
Revenue₹ Cr · Standalone050100150FY 2019: ₹91 Cr91.1FY 2019FY 2020: ₹71 Cr · -22.5% YoY70.6-22.5%FY 2020FY 2021: ₹97 Cr · +36.8% YoY96.6+36.8%FY 2021FY 2022: ₹76 Cr · -21.7% YoY75.6-21.7%FY 2022FY 2023: ₹78 Cr · +3.3% YoY78.1+3.3%FY 2023FY 2024: ₹84 Cr · +7.1% YoY83.7+7.1%FY 2024FY 2025: ₹115 Cr · +37.5% YoY115+37.5%FY 2025FY 2026: ₹86 Cr · -25.3% YoY85.9-25.3%FY 2026
Net Profit₹ Cr · Standalone0102030FY 2019: ₹10 Cr10.2FY 2019FY 2020: ₹7 Cr · -30.2% YoY7.1-30.2%FY 2020FY 2021: ₹14 Cr · +90.1% YoY13.6+90.1%FY 2021FY 2022: ₹9 Cr · -33.3% YoY9-33.3%FY 2022FY 2023: ₹6 Cr · -28.7% YoY6.4-28.7%FY 2023FY 2024: ₹16 Cr · +145% YoY15.8+145%FY 2024FY 2025: ₹24 Cr · +53% YoY24.2+53%FY 2025FY 2026: ₹16 Cr · -32.2% YoY16.4-32.2%FY 2026
Quarterly Revenue₹ Cr · vs same quarter last year02040Q1'25: ₹32 Cr31.7Q1'25Q2'25: ₹32 Cr32.2Q2'25Q3'25: ₹23 Cr23Q3'25Q4'25: ₹28 Cr28.1Q4'25Q1'26: ₹19 Cr · -40.5% YoY18.8-40.5%Q1'26Q2'26: ₹19 Cr · -40.9% YoY19-40.9%Q2'26Q3'26: ₹22 Cr · -6.2% YoY21.6-6.2%Q3'26Q4'26: ₹26 Cr · -5.9% YoY26.5-5.9%Q4'26
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹85.9 Cr ₹115.01 Cr ₹83.66 Cr ₹78.12 Cr ₹75.61 Cr ₹96.57 Cr ₹70.58 Cr ₹91.08 Cr
Other Income ₹9.9 Cr ₹9.11 Cr ₹6.63 Cr ₹6.9 Cr ₹4.81 Cr ₹3.77 Cr ₹5.89 Cr ₹5.16 Cr
Total Income ₹95.8 Cr ₹124.11 Cr ₹90.29 Cr ₹85.01 Cr ₹80.42 Cr ₹100.34 Cr ₹76.47 Cr ₹96.24 Cr
Cost of Materials Consumed ₹39.87 Cr ₹48.14 Cr ₹39.68 Cr ₹41.4 Cr ₹38.35 Cr ₹48.97 Cr ₹38.68 Cr ₹49.23 Cr
Purchases of Stock-in-Trade ₹2.64 Cr ₹1.56 Cr ₹69.52 Lakh ₹70.64 Lakh ₹66.08 Lakh ₹1.15 Cr ₹4.28 Cr ₹1.54 Cr
Changes in Inventories -₹6.97 Cr ₹3.32 Cr -₹3.13 Cr ₹3.64 Cr ₹71.21 Lakh -₹5.05 Lakh -₹2.94 Cr ₹65,000
Employee Benefit Expense ₹15.92 Cr ₹14.74 Cr ₹11.2 Cr ₹11.13 Cr ₹11.23 Cr ₹10.18 Cr ₹9.7 Cr ₹9.84 Cr
Finance Costs ₹17.14 Lakh ₹9.76 Lakh ₹2,000 ₹33.85 Lakh ₹14.11 Lakh ₹4.25 Lakh ₹5.81 Lakh ₹2.3 Lakh
Depreciation & Amortisation ₹2.14 Cr ₹2.01 Cr ₹1.98 Cr ₹2.18 Cr ₹1.99 Cr ₹1.98 Cr ₹2.01 Cr ₹1.9 Cr
Other Expenses ₹19.24 Cr ₹21.01 Cr ₹18.98 Cr ₹17.43 Cr ₹16.45 Cr ₹20.47 Cr ₹15.56 Cr ₹18.2 Cr
Total Expenses ₹72.99 Cr ₹90.87 Cr ₹69.4 Cr ₹76.83 Cr ₹69.53 Cr ₹82.74 Cr ₹67.35 Cr ₹80.73 Cr
Profit Before Exceptional Items & Tax ₹22.8 Cr ₹33.24 Cr ₹20.9 Cr ₹8.19 Cr ₹10.9 Cr ₹17.59 Cr ₹9.12 Cr ₹15.51 Cr
Exceptional Items ₹31.25 Lakh -₹76.96 Lakh -₹16.35 Lakh ₹3.81 Lakh ₹95.94 Lakh ₹1.87 Lakh ₹0 ₹0
Profit Before Tax ₹23.11 Cr ₹32.47 Cr ₹20.73 Cr ₹8.23 Cr ₹11.86 Cr ₹17.61 Cr ₹9.12 Cr ₹15.51 Cr
Total Tax Expense ₹6.73 Cr ₹8.31 Cr ₹4.94 Cr ₹1.78 Cr ₹2.81 Cr ₹4.06 Cr ₹1.99 Cr ₹5.29 Cr
Net Profit ₹16.38 Cr ₹24.16 Cr ₹15.79 Cr ₹6.45 Cr ₹9.05 Cr ₹13.55 Cr ₹7.13 Cr ₹10.22 Cr
Other Comprehensive Income -₹7.94 Cr ₹26.81 Lakh ₹6.91 Cr -₹7.7 Cr ₹10.36 Cr ₹7.42 Cr -₹4.37 Cr -₹11.92 Cr
Total Comprehensive Income ₹8.44 Cr ₹24.42 Cr ₹22.7 Cr -₹1.26 Cr ₹19.41 Cr ₹20.97 Cr ₹2.76 Cr -₹1.71 Cr
EBITDA (computed) ₹25.11 Cr ₹35.35 Cr ₹22.87 Cr ₹10.71 Cr ₹13.03 Cr ₹19.62 Cr ₹11.18 Cr ₹17.43 Cr
Basic EPS ₹45.85 ₹67.61 ₹44.19 ₹18.04 ₹25.32 ₹37.94 ₹19.96 ₹8.75
Diluted EPS ₹45.85 ₹67.61 ₹44.19 ₹18.04 ₹0.00 ₹0.00 ₹19.96 ₹8.75
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹240.66 Cr ₹229.46 Cr ₹205.68 Cr ₹174.35 Cr ₹189.9 Cr ₹167.54 Cr ₹144.29 Cr ₹135.77 Cr
Non-current Assets ₹63.7 Cr ₹52.92 Cr ₹51.83 Cr ₹50.81 Cr ₹59.09 Cr ₹56.7 Cr ₹48.45 Cr ₹52.14 Cr
Current Assets ₹176.97 Cr ₹176.55 Cr ₹153.85 Cr ₹123.54 Cr ₹130.8 Cr ₹110.84 Cr ₹95.83 Cr ₹83.63 Cr
Property, Plant & Equipment ₹43.17 Cr ₹21.74 Cr ₹23.27 Cr ₹24.28 Cr ₹22.77 Cr ₹20.41 Cr ₹21.49 Cr ₹22.11 Cr
Inventories ₹20.53 Cr ₹9.87 Cr ₹15.16 Cr ₹12.5 Cr ₹18.36 Cr ₹21.67 Cr ₹19.3 Cr ₹16.17 Cr
Trade Receivables ₹29.43 Cr ₹33.64 Cr ₹28.19 Cr ₹23.42 Cr ₹38.11 Cr ₹39.16 Cr ₹34.41 Cr ₹30.32 Cr
Cash & Equivalents ₹1.37 Cr ₹3.41 Cr ₹2.07 Cr ₹6.13 Cr ₹2.51 Cr ₹2.32 Cr ₹1.11 Cr ₹2.97 Cr
Equity (Net Worth) ₹209.11 Cr ₹201.21 Cr ₹177.5 Cr ₹154.8 Cr ₹156.05 Cr ₹136.64 Cr ₹115.67 Cr ₹113.77 Cr
Equity Share Capital ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr ₹3.57 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Borrowings (Current) ₹4.33 Cr ₹3.56 Cr ₹0 ₹0 ₹6.04 Cr ₹6.25 Cr ₹5.91 Cr ₹1.44 Cr
Total Debt (computed) ₹4.33 Cr ₹3.56 Cr ₹0 ₹0 ₹6.04 Cr ₹6.25 Cr ₹5.91 Cr ₹1.44 Cr
Current Liabilities ₹27.31 Cr ₹24.96 Cr ₹24.9 Cr ₹11.86 Cr ₹25.52 Cr ₹27.79 Cr ₹25.09 Cr ₹18.02 Cr
Total Liabilities ₹31.55 Cr ₹28.26 Cr ₹28.18 Cr ₹19.55 Cr ₹33.84 Cr ₹30.9 Cr ₹28.62 Cr ₹22 Cr
Metrics FY 2026 FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹15.62 Cr -₹1.22 Cr -₹5.46 Cr ₹12.67 Cr ₹6.08 Cr
Investing Cash Flow -₹17.71 Cr -₹15.19 Lakh ₹1.4 Cr -₹2.61 Cr -₹6.05 Cr
Financing Cash Flow ₹5.98 Lakh ₹2.71 Cr ₹66,000 -₹6.43 Cr ₹14.91 Lakh
Capital Expenditure ₹21.09 Cr ₹2.95 Cr ₹99.1 Lakh ₹1.95 Cr ₹5.55 Cr
Free Cash Flow (computed) -₹5.48 Cr -₹4.17 Cr -₹6.46 Cr ₹10.72 Cr ₹53.54 Lakh
Dividends Paid ₹53.59 Lakh ₹71.45 Lakh ₹0 ₹0 ₹0
Net Change in Cash -₹2.03 Cr ₹1.33 Cr -₹4.06 Cr ₹3.62 Cr ₹18.15 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹26.48 Cr ₹21.56 Cr ₹19.03 Cr ₹18.82 Cr ₹28.13 Cr ₹22.99 Cr ₹32.23 Cr ₹31.66 Cr
Other Income ₹2.65 Cr ₹2.49 Cr ₹2.71 Cr ₹2.05 Cr ₹2.48 Cr ₹2.52 Cr ₹2.54 Cr ₹1.56 Cr
Total Income ₹29.13 Cr ₹24.06 Cr ₹21.74 Cr ₹20.87 Cr ₹30.62 Cr ₹25.51 Cr ₹34.77 Cr ₹33.22 Cr
Cost of Materials Consumed ₹11.3 Cr ₹12.93 Cr ₹7.31 Cr ₹8.33 Cr ₹11.39 Cr ₹8.98 Cr ₹15.97 Cr ₹11.8 Cr
Purchases of Stock-in-Trade ₹26.02 Lakh ₹75.06 Lakh ₹80.97 Lakh ₹81.89 Lakh ₹42.54 Lakh ₹16.09 Lakh ₹27.31 Lakh ₹70.21 Lakh
Changes in Inventories -₹99.3 Lakh -₹5 Cr -₹56.54 Lakh -₹41.46 Lakh ₹2.75 Cr ₹32.3 Lakh -₹68.8 Lakh ₹92.62 Lakh
Employee Benefit Expense ₹4.39 Cr ₹4.4 Cr ₹3.7 Cr ₹3.42 Cr ₹3.83 Cr ₹3.38 Cr ₹3.93 Cr ₹3.59 Cr
Finance Costs ₹1.01 Lakh ₹8,000 ₹10.27 Lakh ₹5.79 Lakh ₹3.86 Lakh ₹1.93 Lakh ₹1.13 Lakh ₹2.84 Lakh
Depreciation & Amortisation ₹54.17 Lakh ₹68.69 Lakh ₹45.22 Lakh ₹45.32 Lakh ₹50.61 Lakh ₹50.15 Lakh ₹50.9 Lakh ₹49.39 Lakh
Other Expenses ₹5.32 Cr ₹6.59 Cr ₹2.85 Cr ₹4.48 Cr ₹7.05 Cr ₹3.82 Cr ₹6.24 Cr ₹3.9 Cr
Total Expenses ₹20.83 Cr ₹20.36 Cr ₹14.65 Cr ₹17.15 Cr ₹25.99 Cr ₹17.19 Cr ₹26.24 Cr ₹21.44 Cr
Profit Before Exceptional Items & Tax ₹8.3 Cr ₹3.7 Cr ₹7.09 Cr ₹3.72 Cr ₹4.62 Cr ₹8.31 Cr ₹8.53 Cr ₹11.77 Cr
Exceptional Items -₹99,000 ₹0 ₹32.25 Lakh ₹0 -₹76.96 Lakh ₹0 ₹0 ₹0
Profit Before Tax ₹8.29 Cr ₹3.7 Cr ₹7.42 Cr ₹3.72 Cr ₹3.85 Cr ₹8.31 Cr ₹8.53 Cr ₹11.77 Cr
Total Tax Expense ₹3.06 Cr ₹92 Lakh ₹1.6 Cr ₹1.16 Cr ₹1.02 Cr ₹2.17 Cr ₹2.15 Cr ₹2.97 Cr
Net Profit ₹5.22 Cr ₹2.78 Cr ₹5.82 Cr ₹2.56 Cr ₹2.83 Cr ₹6.14 Cr ₹6.38 Cr ₹8.8 Cr
Other Comprehensive Income -₹9.42 Cr -₹2.02 Cr -₹2.13 Cr ₹5.63 Cr -₹12.57 Cr ₹1.25 Cr ₹2.84 Cr ₹8.74 Cr
Total Comprehensive Income -₹4.2 Cr ₹76.03 Lakh ₹3.69 Cr ₹8.2 Cr -₹9.74 Cr ₹7.4 Cr ₹9.22 Cr ₹17.54 Cr
EBITDA (computed) ₹8.85 Cr ₹4.38 Cr ₹7.65 Cr ₹4.23 Cr ₹5.17 Cr ₹8.84 Cr ₹9.05 Cr ₹12.3 Cr
Basic EPS ₹14.62 ₹7.77 ₹16.29 ₹7.18 ₹7.91 ₹17.20 ₹17.86 ₹24.64
Diluted EPS ₹14.62 ₹7.77 ₹16.29 ₹7.18 ₹7.91 ₹17.20 ₹17.86 ₹24.64
Latest 8 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Coral Laboratories Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Coral Laboratories Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 71.51%, retail and other public shareholders hold 28.49% of Coral Laboratories Limited. The company had 4,084 shareholders on record.

Promoters: 71.51%Retail & Others: 28.49%
Mar 2026
QUARTER
71.51% Promoters
28.49% Retail & Others
Promoter holding - history
Now 71.51% · Mar 2026High 71.51% · Jun 2023Low 71.51% · Jun 2023
70%70.8%71.5%72.3%73%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 71.51%Sep 2023: 71.51%Dec 2023: 71.51%Mar 2024: 71.51%Jun 2024: 71.51%Sep 2024: 71.51%Dec 2024: 71.51%Mar 2025: 71.51%Jun 2025: 71.51%Sep 2025: 71.51%Dec 2025: 71.51%Mar 2026: 71.51%71.51%71.51%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters71.51%71.51%71.51%71.51%71.51%71.51%
Public28.49%28.49%28.49%28.49%28.49%28.49%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters71.51%71.51%71.51%
Public28.49%28.49%28.49%
Promoter change (YoY, %pts)+0.00+0.00-

Charges & Borrowings of Coral Laboratories Limited

Open charges
₹31.05 Cr
Satisfied charges
₹1.97 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹31.05 Cr
Latest charge details
DateLenderAmountStatus
17 Jan 2019 Hdfc Bank Limited ₹23.35 Cr Open
28 Dec 2006 Hdfc Bank Limited ₹7.7 Cr Open
13 Jul 2000 Bank of Baroda ₹1.97 Cr Satisfied

Total charge records: 3 View all charges

Employees and EPFO Compliance at Coral Laboratories Limited

Coral Laboratories Limited has a workforce of 103 employees as of Mar 29, 2025.

Employee count
103
Active EPFO establishments
2
Employee growth
13.19%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Coral Laboratories Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Coral Laboratories Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Coral Laboratories Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Coral Laboratories Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Coral Laboratories Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Coral Laboratories Limited

MSME Payment Delays by Coral Laboratories Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Coral Laboratories Limited

Subsidiaries & Group Companies of Coral Laboratories Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Coral Laboratories Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Coral Laboratories Limited

MCA Filings & Documents of Coral Laboratories Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Coral Laboratories Limited

Activity
26 Sep 2025
Coral Laboratories Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Coral Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
09 Aug 2024
Pooja Sanjiv Hindia was appointed as a Director on 09 Aug 2024 & has been associated with this company since 1 year 11 months.
Directors
01 Aug 2024
Dhwani Karna Desai was appointed as a Company Secretary on 01 Aug 2024 & has been associated with this company since 1 year 11 months.
Directors
08 Jan 2024
Sushma Shashi Kadkade was appointed as a Nodal Officer on 08 Jan 2024 & has been associated with this company since 2 years 6 months.
Charges
17 Feb 2023
A charge with Hdfc Bank Limited of Rs. 23.35 Cr registered on 17 Jan 2019 with Charge ID 100240261 was modified on 17 Feb 2023.

Frequently Asked Questions about Coral Laboratories Limited

Coral Laboratories Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 06 February 1997 (29+ years old) and is registered under CIN L24231MH1997PLC422233. Listed on BSE: 524506. The company has 103 employees.

Coral Laboratories Limited reported revenue of ₹90.29 Cr for FY 2024 (up 6.00% YoY).

The current directors of Coral Laboratories Limited are:

The primary industry of Coral Laboratories Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Coral Laboratories Limited is listed on BSE with code 524506.

Coral Laboratories Limited can be reached at the registered office: Shed No. 3B Patanwala Compound, Opp Shreyas Lbs Marg Ghatkopar West, Mumbai, Maharashtra, India – 400086, or through the website corallab.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available